Gene · 56034
Papers1,955
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,955
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular mechanisms of coronary artery disease risk at the PDGFD locus. | Nat Commun | 2023 | 36792607 | PubTator, text mining | PubMed |
| The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis. | Int J Mol Sci | 2023 | 36769282 | PubTator, text mining | PubMed |
| The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism. | Int J Mol Sci | 2023 | 36768977 | PubTator, text mining | PubMed |
| Inflammatory Treatment Used to Mimic Osteoarthritis and Patients' Synovial Fluid Have Divergent Molecular Impact on Chondrocytes In Vitro. | Int J Mol Sci | 2023 | 36768948 | PubTator, text mining | PubMed |
| Bevacizumab versus Ramucirumab in EGFR-Mutated Metastatic Non-Small-Cell Lung Cancer Patients: A Real-World Observational Study. | Cancers (Basel) | 2023 | 36765600 | PubTator, text mining | PubMed |
| Prospective use of amniotic mesenchymal stem cell metabolite products for tissue regeneration. | J Biol Eng | 2023 | 36759827 | PubTator, text mining | PubMed |
Single-Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus-Associated (HPVA) and Non-HPVA Adenocarcinoma. | Adv Sci (Weinh) | 2023 | 36725337 | PubTator, text mining | PubMed |
| An integrated multi-omics analysis of sleep-disordered breathing traits implicates P2XR4 purinergic signaling. | Commun Biol | 2023 | 36721044 | PubTator, text mining | PubMed |
| The blood vasculature instructs lymphatic patterning in a SOX7-dependent manner. | EMBO J | 2023 | 36715213 | PubTator, text mining | PubMed |
| Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial. | Transl Neurodegener | 2023 | 36703196 | PubTator, text mining | PubMed |
| Peripheral Blood Gene Expression Profile of Infants with Atopic Dermatitis. | JID Innov | 2023 | 36699197 | PubTator, text mining | PubMed |
| Signaling Pathways and Potential Therapeutic Strategies in Cardiac Fibrosis. | Int J Mol Sci | 2023 | 36675283 | PubTator, text mining | PubMed |
| Distinguishing Plasmin-Generating Microvesicles: Tiny Messengers Involved in Fibrinolysis and Proteolysis. | Int J Mol Sci | 2023 | 36675082 | PubTator, text mining | PubMed |
| The Role of Inflammation and Therapeutic Concepts in Diabetic Retinopathy-A Short Review. | Int J Mol Sci | 2023 | 36674535 | PubTator, text mining | PubMed |
| Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers. | Biomedicines | 2023 | 36672620 | PubTator, text mining | PubMed |
| Heparin-Induced Changes of Vascular Endothelial Growth Factor (VEGF165) Structure. | Biomolecules | 2023 | 36671483 | PubTator, text mining | PubMed |
| Biological and Mechanical Factors and Epigenetic Regulation Involved in Tendon Healing. | Stem Cells Int | 2023 | 36655033 | PubTator, text mining | PubMed |
| Clinical and genetic factors associated with radiographic damage in patients with ankylosing spondylitis. | Ann Rheum Dis | 2023 | 36543524 | PubTator, text mining | PubMed |
| Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors. | Cancer Res | 2023 | 36543251 | PubTator, text mining | PubMed |
| Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer. | Mol Ther | 2023 | 36384875 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/56034/papers?page=13